Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Brown Brothers Harriman & Co.

Brown Brothers Harriman & Co. raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 26.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,373 shares of the medical equipment provider's stock after buying an additional 714 shares during the quarter. Brown Brothers Harriman & Co.'s holdings in Intuitive Surgical were worth $1,761,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. Bennett Selby Investments LP lifted its position in Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after purchasing an additional 17 shares during the last quarter. Onefund LLC raised its position in shares of Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after buying an additional 18 shares in the last quarter. LVW Advisors LLC lifted its holdings in shares of Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after acquiring an additional 19 shares during the last quarter. Wesbanco Bank Inc. grew its position in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after acquiring an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC increased its stake in Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock worth $542,000 after acquiring an additional 19 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Remove Ads

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the business's stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last quarter. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $1.09 during trading hours on Tuesday, hitting $496.36. 1,609,268 shares of the stock traded hands, compared to its average volume of 1,530,402. The firm's 50 day moving average price is $554.33 and its 200-day moving average price is $532.98. The stock has a market capitalization of $176.79 billion, a price-to-earnings ratio of 77.44, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Analysts Set New Price Targets

A number of research firms have weighed in on ISRG. Robert W. Baird reduced their price target on Intuitive Surgical from $707.00 to $600.00 and set an "outperform" rating on the stock in a report on Tuesday, March 18th. Bernstein Bank lifted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a report on Thursday, December 5th. Royal Bank of Canada lifted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, Erste Group Bank lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.